The largest database of trusted experimental protocols

Ppack packaging plasmid mix

Manufactured by System Biosciences
Sourced in United States, China

The PPACK Packaging Plasmid Mix is a set of plasmid vectors designed for the production of lentiviral particles. The mix includes the necessary components for the packaging of lentiviral vectors, enabling the generation of infectious, replication-incompetent lentiviral particles.

Automatically generated - may contain errors

23 protocols using ppack packaging plasmid mix

1

Eukaryotic Expression Vectors for Cell Biology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eukaryotic expression vectors encoding Drp1, Fis1, DNA-PKcs and Met were generated through the insertion of PCR-amplified fragments into a pcDNA3 vector (Invitrogen, CA, USA). Serine 616 was replaced with aspartic acid to establish the Drp1 phosphorylation-mimetic mutant (Drp1S616D). Threonine 34 was replaced with aspartic acid to construct the Fis1 phosphorylation-mimetic mutant (Fis1T34D). For lentiviral production, HEK293T cells were co-transfected with recombinant lentiviral vectors and a pPACK Packaging Plasmid Mix (System Biosciences) using MegaTran reagent (OriGene, Beijing, China). The target cells were infected with the lentiviruses according to the manufacturer’s instructions. siRNA against DNA-PKcs was established and transfected into cells according to our recent reports [37 (link), 43 (link)].
+ Open protocol
+ Expand
2

Establishing Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 293T embryonic kidney cells and ZR75-1, MCF7 and MDA-MB-231 breast cancer cells were routinely cultured in DMEM (Invitrogen) containing 10% FBS (Hyclone). The HUVEC cells were purchased from ATCC (American Type Culture Collection) and cultured in DMEM (Invitrogen) containing 10% FBS. Lipofectamine 2000 reagent was used for transfections following the manufacturer's protocol (Invitrogen). Lentiviruses were produced by cotransfection of 293 T cells with recombinant lentivirus vectors and pPACK Packaging Plasmid Mix (System Biosciences) using Megatran reagent (Origene). Lentiviruses were collected 48 hours after transfection and added to the medium of target cells with 8 μg/ml polybrene (Sigma-Aldrich). Stable cell lines were selected in 1 μg/ml puromycin for approximately 2 months. Pooled clones or individual clones were screened by standard immunoblot protocols and produced similar results. Luciferase reporter assays were performed as described previously [50 (link)].
+ Open protocol
+ Expand
3

Lentiviral Vector Production for miR-890 and CD147

Check if the same lab product or an alternative is used in the 5 most similar protocols
293TN cells in logarithmic phase were seeded in 10 cm culture dishes at 1 × 105 cells by using DMEM medium containing 10% FBS and cultured at 37 °C in 5% CO2 for 24 h. 2 μg of recombinants vector and 10 μg of pPACK Packaging Plasmid Mix (System Biosciences) were co-transfected into 293TN using Lipofectamine2000 transfection reagent (Invitrogen) according to the manufacturer’s protocol. The supernatant was harvested and cleared by centrifugation at 5000×g at 4 °C for 5 min and then passed through a disposable filter (0.45 μm, Millipore, MI, USA) after 48 h of transfection. The virus titer was determined by a gradient dilution method. The recombinant lentivirus were named Lv-miR-890 and Lv-CD147 and stored at − 80 °C freezer after dispensing.
+ Open protocol
+ Expand
4

Lentivirus Production and Titration

Check if the same lab product or an alternative is used in the 5 most similar protocols
One day before transfection, 293TN cells were seeded into 10 cm dishes. Two micrograms of each pSIH1-shRNA-RPS5 vector or pSIH-NC or pSIH-shRNA-RPS5 and 10 μg pPACK Packaging Plasmid Mix (System Biosciences) were co-transfected using Lipofectamine 2000 (Invitrogen) in accordance with the manufacturer’s protocol. The medium was replaced with DMEM plus 1% FBS. Forty-eight hours later, the supernatant was collected and then cleared by centrifugation at 5000 × g at 4 °C for 5 min, and passed through a 0.45 μM PVDF membrane (Millipore, Shanghai, China). The titer of virus was determined by gradient dilution. The packaged lentiviruses were named as Lv-shRNA-RPS5, Lv-NC and Lv-RPS5.
+ Open protocol
+ Expand
5

Genetic Manipulation of LDHA and LDHB

Check if the same lab product or an alternative is used in the 5 most similar protocols
The 293T human embryonic kidney cell line, and PANC-1 and Capan-2 pancreatic cancer cell lines were purchased from the American Type Culture Collection and were previously tested for mycoplasma contamination. Cells were routinely cultured in Dulbecco’s Modified Eagle Medium (Macgene, China) with 10% fetal bovine serum (Hyclone, USA). The FLAG-tagged LDHB eukaryotic expression vector was generated by inserting PCR-amplified fragments of the LDHB gene into pcDNA3 (Invitrogen, USA). Lentiviral shRNA vectors of LDHA and LDHB were constructed by cloning short hairpin RNA fragments into pSIH-H1-Puro (System Biosciences, USA). Target sequences are as follows, LDHA shRNA: 5’- ATCCAGTGGATATCTTGACCTACG -3’; LDHB shRNA: 5’- GGATATACCAACTGGGCTATT -3’. Lentiviruses were produced by co-transfection of HEK293T cells with recombinant lentivirus vectors and pPACK Packaging Plasmid Mix (System Biosciences, USA) using PEI reagent (Polyscience, USA). Lentiviruses were used to infect target cells in accordance with the manufacturers’ instructions. Myc-TERT, Flag-TERT, and GST-TERT plasmids were described previously (15 (link)). Sodium pyruvate, Sodium lactate, Methyl pyruvate and IPTG were products from Sigma (USA). 2-DG and AT-101 were purchased from Selleck (USA).
+ Open protocol
+ Expand
6

Lentiviral-mediated SIRT1 silencing in AFLD mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
SIRT1 siRNA sequence (GCAGGTTGCAGGAATCCAAAG) was synthesized and linked with lentivirus vector using a carrier LV3 (H1/GFP and Puro) from Shanghai GenePharma Technology Co Ltd (Shanghai, People’s Republic of China). The sequence was linked to the pshRNA-H1-Luc lentivector to construct pshRNA-H1-Luc-SIRT1-siRNA. The constructed vector was cotransfected into 293T cells by Lipofectamine™ 2000 (Thermo Fisher Scientific, Waltham, MA, USA) and pPACK Packaging Plasmid Mix (System Biosciences, Shanghai, People’s Republic of China). After 48-hour culture, viral supernatant was collected and the titer was calculated with diluted lentivirus. Twenty-four AFLD mice were intra-articularly injected with 100 µL supernatants containing the lentivirus-carrying SIRT1 siRNA (1×108 virus titer per injection, two times/day) for 10 days.
+ Open protocol
+ Expand
7

Lentiviral Overexpression of AXL Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were seeded onto 10-cm dish and cotransfected with lentivirus transfer vectors (pCDH-CMV vector carrying AXL, AXL-ICD, AXL-K567R, Flag-AXL) and pPACK Packaging Plasmid Mix (Systems Biosciences) according to manufacturer instructions. Culture medium was concentrated with PEG-it precipitation solution (Systems Biosciences). Pseudoviral particles were suspended in prechilled PBS, portioned into aliquots, and stored at −80°C. For infection of HEK293T cells, MEFs, and HCC827 cells, concentrated virus, together with polybrene (8 μg/ml; Sigma-Aldrich), was used. After 48 h transduction, clones that stably overexpressed AXL were screened with 2.5 μg/ml puromycin for 1 wk. Protein expression levels were evaluated by Western blot.
+ Open protocol
+ Expand
8

Lentiviral Transduction of HER2 Overexpression

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasmid pCMV6.Entry.hHER2 encoding human HER2 (hHER2; GeneBank accession no. NM_004448) was purchased from Origene (Rockville, MD) and a plasmid encoding canine HER2 (cHER2; GeneBank accession no. NP_001003217) was synthesized by Life Technologies. Both transgenes were subcloned into a pCDH expression lentiviral vector containing GFP reporter and puromycin resistance genes (pCDH.CMV-MCS-EF1-GFPpuro; System Biosciences, Mountain View, CA). VSV-G pseudotyped lentiviral particles were generated by transient transfection of 293T cells with the canine or human HER2 encoding pCDH lentiviral vector and pPACK packaging plasmid mix (System Biosciences). Transduced MDA-MB-468 cells were selected using 1ug/ml puromycin and grown in DMEM containing 10% heat-inactivated fetal calf serum and 1% GlutaMax.
+ Open protocol
+ Expand
9

Lentiviral Transduction of 293TN Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
One day before transfection, 293TN cells were seeded into 10 cm dishes. 2 μg of each pSIH1-shRNA-ASLNC07322 vector or pcDH1-Smad4 and 10 μg pPACK Packaging Plasmid Mix (System Biosciences) were co-transfected using Lipofectamine 2000 (Invitrogen) in accordance with the manufacturer’s protocol. The medium was replaced with DMEM plus 10% FBS. 48 h later, the supernatant was harvested and then cleared by centrifugation at 5,000 × g at 4°C for 5 m and passed through a 0.45 μm PVDF membrane (Millipore, MI, USA). The titer of virus was determined by gradient dilution method. The packaged lentiviruses were named as Lv-shASLNC07322. Control virus Lv-NC was produced in the same way.
+ Open protocol
+ Expand
10

Lentiviral Pseudotype Production

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pseudotype lentiviruses were produced in 293T cells by cotransfecting lentiviral pCDH-TDP2 expressing construct and pPACK Packaging Plasmid Mix (System Biosciences), following the manufacturer's instructions. Pseudoviral particles were harvested 48 hours after transfection and concentrated using PEG-it Virus Precipitation Solution.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!